A new umbrella review reveals how GLP-1 therapies shape cardiovascular, renal, and metabolic outcomes in type 2 diabetes while highlighting drug-specific advantages and the need to manage gastrointestinal risks.
Study: Efficacy and…
Study compares GLP-1 drug benefits and finds substantial variation in clinical effects
